Lantheus pre-announces FY2023 revenue ~$1.296B, beating guidance; PYLARIFY up 62%

Lantheus Holdings, Inc.

2023-FY EPS reported $4.65 revenue$1,296,429,000

Worldwide revenue expected $1.295-1.297B, up 38-39% YoY, above prior guidance of $1.255-1.270B.
PYLARIFY revenue $851-853M (+61-62% YoY); DEFINITY ~$279M (+14%); includes $15M RELISTOR milestone.
Company cites over 6 million patients impacted and strong radiopharmaceutical platform momentum.
Full FY2023 results and 2024 financial expectations to be released in late February 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Lantheus Holdings, Inc. reported fiscal year ended December 31, 2023 results: revenue $1.295 - 1.297 billion.

Period: fiscal year ended December 31, 2023
Revenue: $1.295 - 1.297 billion
Result: preliminary results

Exact text from the filing

Lantheus Reports Preliminary Fiscal Year 2023 Revenue Full year 2023 worldwide revenue expected to be in the range of $1.295 – 1.297 billion

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

Lantheus Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-000888

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.